Intramyocardial injection of allogeneic human induced pluripotent stem cell-derived cardiomyocytes in advanced ischemic heart failure: an early-stage randomized trial

Source: Nature.com· He Zhang, Phlippe Menasche, Jiahao Fan, Ling Gao, Hanqing Luo, Yunxing Xue, Xiyu Zhu, Qian Wang, Chengwu Li, Yongsheng Xu, Alex Zhang, Jiaxian Wang, Dongjin Wang· August 19, 2026
Intramyocardial injection of allogeneic human induced pluripotent stem cell-derived cardiomyocytes in advanced ischemic heart failure: an early-stage randomized trial

In an early-stage randomized trial, the safety and efficacy of intramyocardial injection of hiPSC-derived cardiomyocytes in patients with advanced heart failure were evaluated.

This story was reported by Nature.com. Read the full original article:
Read on Nature.com

More in Ethics & Safety

View all